核酸分离和纯化市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

核酸分离和纯化市场按技术(基于柱的纯化、基于磁珠的纯化和基于试剂的纯化)、产品、应用、最终用户和地理位置进行细分。

市场快照

Nucleic Acid Isolation and Purification Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.6 %
Nucleic Acid Isolation and Purification Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计核酸分离和纯化市场在预测期内的复合年增长率为 6.6%。核酸分离纯化市场的增长是由于技术的快速进步、核酸检测在诊断中的广泛应用以及生物技术和医疗保健研发资金的增加。

  • 核酸在许多疾病的测试中具有许多诊断应用,例如性病、先天性异常、癌症等。
  • 根据美国卫生与公众服务部的数据,截至 2016 年,全球约有 3670 万艾滋病毒/艾滋病感染者。其中,210 万是儿童(15 岁以上)。世卫组织表示,全世界每天有超过 100 万例性传播感染,估计有 5 亿人感染了单纯疱疹病毒 (HSV),还有 2.9 亿女性感染了人乳头瘤病毒 (HPV)。因此,所有性病都可以通过核酸分离和鉴定程序进行诊断,这意味着所研究的市场有望在全球范围内增加。
  • 由于技术的快速进步,当前的市场也在增长,例如聚合酶链式反应(原始的核酸扩增技术),它改变了临床微生物学家在临床环境中查看和使用核酸技术的方法。

报告范围

根据报告的范围,核酸分离和纯化是分子生物学技术中的一个过程,例如克隆、测序、聚合酶链式反应和其他技术。这些技术在基因工程、生命科学研究、法医学和分子诊断领域有各种应用。核酸分离有助于在更短的时间内处理更多样品,最大限度地减少核酸损失降解,并提高实验室效率和有效性。它还有助于核酸的纯化。核酸分离和纯化市场按技术、产品、应用、最终用户和地理位置进行细分。

By Technology
Column-based Purification
Magnetic Bead-based Purification
Reagent-based Purification
By Product
Kits and Reagents
Equipment
Other Products
By Application
Total RNA Isolation and Purification
mRNA Isolation and Purification
microRNA Isolation and Purification
Plasmid DNA Isolation and Purification
Genomic DNA Isolation and Purification
Blood DNA Isolation and Purification
PCR Clean-up
Other Nucleic Acid Isolation and Purification Applications
By End User
Hospitals
Academic and Research Institutes
Pharmaceutical/Biotechnology Industry
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

设备板块有望在核酸分离纯化市场占据主要市场份额

  • 所研究市场的设备部分正在以良好的速度增长。分子诊断领域取得了重大进展,促进了核酸分离和纯化技术的快速和持续发展,这是由绘制许多疾病背后的遗传风险因素所提供的新知识所推动的,其中生活方式在这些疾病中起着重要作用。玩。 
  • 根据世界卫生组织 (WHO) 2020 年的报告,α 和 β 地中海贫血是世界上最常见的遗传性单基因疾病。世界许多地区的地贫负担是​​一个重大的公共卫生问题。例如,在伊朗,据估计每年约有 8,000 名孕妇面临这种疾病的风险。此外,据估计,遗传性疾病唐氏综合症的发病率在全球每 1,000 名活产婴儿中有 1 名至 1,100 名活产婴儿中有 1 名。 
  • 因此,遗传疾病的高发病率以及实验室自动化的增长和可变性的降低可能导致所研究市场的设备部分的增长。
Nucleic Acid Isolation and Purification Market Share

北美预计将在市场上占有重要份额,预计在预测期内也将如此

  • 由于该国下游工艺的使用率非常高,预计北美将在核酸分离和纯化市场占据主要市场份额。市场的增长还归因于技术的快速进步、核酸检测在诊断中的广泛应用推动了市场、生物技术和医疗保健领域的研发资金增加。 
  • 根据疾病控制和预防中心 (CDC) 的数据,在美国,每 5,000 名男性新生儿中就有 1 名患有 A 型血友病。每年大约有 400 名婴儿出生时患有 A 型血友病。 
  • 此外,完善的医疗保健基础设施的存在也在很大程度上推动了整个区域市场的增长。
Nucleic Acid Isolation and Purification Market Growth

竞争格局

核酸分离和纯化市场是​​分散竞争的,由几个主要参与者组成。全球核酸分离纯化市场近期的一些市场趋势是新产品开发、并购和合作。Agilent Technologies、Bio-Rad Laboratories Inc.、Danaher Corporation、F. Hoffmann-La Roche Ltd、GE Healthcare、Promega Corporation、Qiagen NV 和 Thermo Fisher Scientific Inc. 是核酸分离和纯化市场的主要参与者.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rapid Technological Advancements Boosting the Market Growth

      2. 4.2.2 Wide-range Applications of Nucleic Acid Testing in Diagnostics Boosting the Market

      3. 4.2.3 Rise in the R&D Funding in Biotechnology and Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Low Penetration in the Emerging Markets

      2. 4.3.2 Increasing Cost of Automated Instruments

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technology

      1. 5.1.1 Column-based Purification

      2. 5.1.2 Magnetic Bead-based Purification

      3. 5.1.3 Reagent-based Purification

    2. 5.2 By Product

      1. 5.2.1 Kits and Reagents

      2. 5.2.2 Equipment

      3. 5.2.3 Other Products

    3. 5.3 By Application

      1. 5.3.1 Total RNA Isolation and Purification

      2. 5.3.2 mRNA Isolation and Purification

      3. 5.3.3 microRNA Isolation and Purification

      4. 5.3.4 Plasmid DNA Isolation and Purification

      5. 5.3.5 Genomic DNA Isolation and Purification

      6. 5.3.6 Blood DNA Isolation and Purification

      7. 5.3.7 PCR Clean-up

      8. 5.3.8 Other Nucleic Acid Isolation and Purification Applications

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Academic and Research Institutes

      3. 5.4.3 Pharmaceutical/Biotechnology Industry

      4. 5.4.4 Other End Users

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East & Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East & Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies

      2. 6.1.2 Bio-Rad Laboratories Inc.

      3. 6.1.3 Thermo Fisher Scientific

      4. 6.1.4 BioVision Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 GE Healthcare

      8. 6.1.8 Merck KGaA (Sigma-Aldrich Corporation)

      9. 6.1.9 Promega Corporation

      10. 6.1.10 Qiagen NV

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Nucleic Acid Isolation and Purification Market market is studied from 2018 - 2026.

The Nucleic Acid Isolation and Purification Market is growing at a CAGR of 6.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Agilent Technologies, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare, Thermo Fisher Scientific are the major companies operating in Nucleic Acid Isolation and Purification Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!